Impact of patient and program factors on default during treatment of multidrug-resistant tuberculosis
Authors:
- 1 July 2012
- journal article
- Published by International Union Against Tuberculosis and Lung Disease in The International Journal of Tuberculosis and Lung Disease
- Vol. 16 (7) , 955-960
Abstract
SETTING: In the Philippines, programmatic treatment of drug-resistant tuberculosis (TB) was initiated by the Tropical Disease Foundation in 1999 and transitioned to the National TB Program in 2006. OBJECTIVE: To determine patient and socio-demographic characteristics associated with default, and the impact of patient support measures on default. DESIGN: Retrospective cohort analysis of 583 MDR-TB patients treated from 1999 to 2006. RESULTS: A total of 88 (15%) patients defaulted from treatment. The median follow-up time for patients who defaulted was 289 days (range 1–846). In multivariate analysis adjusted for age, sex and previous TB treatment, receiving a greater number of treatment drugs (≥5 vs. 2–3 drugs, HR 7.2, 95%CI 3.3–16.0, P < 0.001) was significantly associated with an increased risk of default, while decentralization reduced the risk of default (HR 0.3, 95%CI 0.2–0.7, P < 0.001). CONCLUSION: Improving access to treatment for MDR-TB through decentralization of care to centers near the patient's residence reduced the risk of default. Further research is needed to evaluate the feasibility, impact and cost-effectiveness of decentralized care models for MDR-TB treatment.Keywords
This publication has 11 references indexed in Scilit:
- A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant TuberculosisPharmacoEconomics, 2012
- Nationwide drug resistance survey of tuberculosis in the Philippines.2009
- Risk Factors and Mortality Associated with Default from Multidrug‐Resistant Tuberculosis TreatmentClinical Infectious Diseases, 2008
- Treating Multidrug‐Resistant Tuberculosis in Tomsk, RussiaAnnals of the New York Academy of Sciences, 2008
- Default from tuberculosis treatment programme in Sagamu, NigeriaNigerian Journal of Medicine, 2006
- Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experienceSocial Science & Medicine, 2004
- Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.2004
- Prevalence and predictors of default from tuberculosis treatment in Hong Kong.2003
- DOTS-Plus for multidrug-resistant tuberculosis in the Philippines: global assistance urgently neededTuberculosis, 2003
- Ambulatory treatment of multidrug-resistant pulmonary tuberculosis patients at a chest clinic.2001